Proteome Systems hits second milestone in the development of a rapid diagnostic test to detect active TB

24-Mar-2006

Proteome Systems announced that its international partner, the Foundation for Innovative New diagnostics (FIND), has signed off on the second Milestone in its Tuberculosis [TB] diagnostic program. Proteome Systems has discovered and patented TB proteins in human sputum and blood that can be used to diagnose active tuberculosis. There is currently no point-of-care [POC] test to detect TB in its active form. This recent milestone involved producing and using antibodies for the detection of these unique TB proteins in clinical samples.

FIND CEO Giorgio Roscigno said that reaching this second milestone is important particularly as it coincides with World TB Day when partners worldwide are renewing their commitment to rally behind the new ten- year Global Plan to stop TB (2006-2015).

Other news from the department research and development

Most read news

More news from our other portals

Under the magnifying glass: The world of microscopy

See the theme worlds for related content

Topic world Antibodies

Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous

View topic world

Topic world Antibodies

Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous

Topic world Diagnostics

Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.

1 whitepaper
View topic world

Topic world Diagnostics

Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.

1 whitepaper